# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 55: Amendment to regulation 67

Extent: E+W+S+N.I.

In regulation 67 (failure to place on the market etc.), in paragraphs (1) and (2) omit “or, in the case of a UKMA(GB) granted after an application under the unfettered access route, in Great Britain”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/55 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-55
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.